1Hall A.Bho GTPases and the actin cytoskeleton[J].Science, 1998,279(5350): 509-514.
2Kaibuchi K,et al.Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells[J].Annu Rev Biochem. 1999,68(1);459 -486.
3Shimokawa H,et al.Rho-kinase is an important therapeutic target in cardiovascular medicine[J]. Arteriorscler Thromb Vasc Biol. 2005,25(9): 1767-1775.
4Somlyo AP,et al.Signal transduction and regulation in smooth muscle[J].Nature.1994,372(2): 231- 236.
5Somiyo AP,et al.Ca^2+sensitivity of smooth muscle and nonmuscle myosin H2modulated by G proteins, kinases,and myosin phosphatase[J].Physiol Rev, 2003,83(4): 1325-1358.
6Ito M,et al.Intracellular signaling pathways for norepinephrine- and endothelin-1-mediated regulation of myocardial cell apoptosis[J].Mol Cell Biochem.2004, 259(1 -2):197-209.
7Muranyi A et al.Phosphorylation of Thr695 and Thr850 on the myosin phosphatase target subunit: inhibitory effects and occurrence in A7r5 cells[J].FEBS Lett. 2005. 579(29): 6611-6615.
8Koyama M,et al Agonist-induced activation of the RhoA/Rho kinase(ROCK)pathway results in inhibition of myosin phosphatase and maintenance of myosin light chain[J]. FEBS Lett. 2000,475(3): 197-200.
9Surks HK,et al.Regulation of myosin phosphatase by a specific interaction with cGMP-dependent protein kinase 1 alpha[J].Science.1999, 286(9):1583- 1587.
10Lee MR,et al.Cyclic GMP causes Ca^2+ desensitization in vascular smooth muscle by activating the myosin light chain phosphatase[J].J.Biol.Chem. 1997(8),272:5063-5068.
5Ming Dong, Bryan P Yah, James K Liao, et al. Rho - ki- nase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases [ J ]. Drug Discovery Today, 2010, 15 : 622 -629.
6Loirand G, Gu~rin P, Pacaud P. Rho kinases in cardiovas- cular physiology and pathophysiology [ J ]. Circulation Re- search, 2006, 98: 322- 334.
7Somlyo AP, Somlyo AV. Ca^2+ sensitivity of smooth muscle and nonmuscle myosin II:modulated by G proteins, kina- ses, and myosin phosphatase[J]. Physiol Rev, 2003, 83 : 1325 - 1358.
8Kawanami D, Matoba K, Kanazawa Y. Thrombin induces MCP - 1 expression through Rho - kinase and subsequent p38MAPK/NF - jB signaling pathway activation in vascular endothelial cells [ J ]. Biochem Biophy Res Commun, 2011,411:798 -803.
9Rolfe BE, Worth NF, World CJ. Rho and vascular disease [J]. htherosclerosis, 2005, 183:1-16.
10Breyer J, Samarin J, Rehm M. Inhibition of Rho kinases increases directional motility of microvascular endothelial cells[J]. Bioehem Pharmacol, 2012, 83:616-626.
